U.S. to invest in Medicines Co, Roche antibiotics development

Sept 21 (Reuters) - The Medicines Co on Wednesday said it will receive up to $132 million in U.S. government funding for development of new antibiotics to fight drug-resistant infections, seen by health officials as a critically important need.